PO136 | PHENOTYPE CHARACTERIZATION OF PATIENTS HOSPITALIZED FOR ACUTE SARS-COV2 INFECTION WITH AND WITHOUT ACUTE CEREBRAL ISCHEMIA
Abstract
Background and Aims. Severe acute SARS-CoV2 infection is a well known model of systemic inflammatory response syndrome (SIRS), characterized by a strong activation of both inflammatory and coagulation pathways leading to multiorgan vascular and microvascular damage. To date, evidence on cerebrovascular complications occurring during acute SARS-CoV2 infection is still scarce. This study aims to estimate the prevalence of acute cerebral ischemia in a large cohort of patients hospitalized for acute SARS-CoV2 infection and to identify the main patient- and disease-related risk factors. Methods. All patients included in the frame of the COVID-19 Network with available information on the primary endpoint (cerebral ischemia yes/no) were enrolled. The Registry, started from March 2020, included all consecutive adults (aged ≥18 years) with a positive RT-PCR result for SARS-CoV-2 at the time of hospital admission. All the Register-related details are reported elsewhere (doi: 10.1016/j.cmi.2020.06.028). Results. Among 1412 patients hospitalized for acute Sars-CoV2 infection, we observed 19 cases with acute cerebral ischemia, including 11 imaging-proven ischemic stroke (IS) and 8 transient ischemic attack (TIA). Patients with acute cerebral ischemia (TIA or IS) were older compared with patients without, with a higher proportion of hypertension, ischemic heart disease/heart failure and history of IS/TIA. As regards laboratory parameters, we observed higher troponin levels and lower platelet and lymphocyte counts in patients with acute cerebral ischemia. Routine hemostatic and inflammatory laboratory parameters were comparable and within normal range in both groups. In-hospital mortality was significantly higher in patients with acute cerebral ischemia during acute SARS-CoV2 infection (Table). Consistently, reservoir mask was used more in these patients (18.8% vs 3.5 %, p=0.001). Conclusions. In a large cohort of patients hospitalized for acute Sars-CoV2 infection (n=1412), we found an incidence proportion of 1.3% of acute cerebral ischemia, 0.8% of IS. Specific patient-related features (age, hypertension, history of IS/TIA, ischemic heart disease/heart failure) seemed to influence the risk of acute cerebral ischemia during acute SARS-CoV-2 infection. In these patients, the early detection of IS/TIA is very important considering its impact on in-hospital mortality risk. Monitoring specific laboratory parameters of disease severity (platelet count, lymphocytes and tropinin level) could be useful.
Related
- Active Helicobacter pylori Infection and Atrial Fibrillation in Patients Hospitalized With Acute Myocardial Infarction
- Isolation, identification, and slow-growth phenotype characterization of a clinically derived Escherichia coli from urinary tract infection
- Association of Peak Expiratory Flow with Pulmonary Fungal Infection in Hospitalized Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Single-Center Retrospective Study.
- Global leadership initiative on malnutrition-based nutritional phenotype and factors associated with the outcomes of hospitalized patients managed by a nutrition support team: A retrospective study
- The pathogenic and clinical characteristics of community-acquired and hospital-acquired co-infection in patients hospitalized with severe fever with thrombocytopenia syndrome
BibTeX
@article{agosti2026po136,
title = {{PO136 | PHENOTYPE CHARACTERIZATION OF PATIENTS HOSPITALIZED FOR ACUTE SARS-COV2 INFECTION WITH AND WITHOUT ACUTE CEREBRAL ISCHEMIA}},
author = {Pasquale Agosti},
journal = {Bleeding, Thrombosis and Vascular Biology},
year = {2026},
month = oct,
url = {https://www.btvb.org/btvb/article/view/952},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - PO136 | PHENOTYPE CHARACTERIZATION OF PATIENTS HOSPITALIZED FOR ACUTE SARS-COV2 INFECTION WITH AND WITHOUT ACUTE CEREBRAL ISCHEMIA
AU - Pasquale Agosti
PY - 2026
DA - 2026/10/26
JO - Bleeding, Thrombosis and Vascular Biology
UR - https://www.btvb.org/btvb/article/view/952
AB - Background and Aims. Severe acute SARS-CoV2 infection is a well known model of systemic inflammatory response syndrome (SIRS), characterized by a strong activation of both inflammatory and coagulation pathways leading to multiorgan vascular and microvascular damage. To date, evidence on cerebrovascular complications occurring during acute SARS-CoV2 infection is still scarce. This study aims to estimate the prevalence of acute cerebral ischemia in a large cohort of patients hospitalized for acute SARS-CoV2 infection and to identify the main patient- and disease-related risk factors. Methods. All patients included in the frame of the COVID-19 Network with available information on the primary endpoint (cerebral ischemia yes/no) were enrolled. The Registry, started from March 2020, included all consecutive adults (aged ≥18 years) with a positive RT-PCR result for SARS-CoV-2 at the time of hospital admission. All the Register-related details are reported elsewhere (doi: 10.1016/j.cmi.2020.06.028). Results. Among 1412 patients hospitalized for acute Sars-CoV2 infection, we observed 19 cases with acute cerebral ischemia, including 11 imaging-proven ischemic stroke (IS) and 8 transient ischemic attack (TIA). Patients with acute cerebral ischemia (TIA or IS) were older compared with patients without, with a higher proportion of hypertension, ischemic heart disease/heart failure and history of IS/TIA. As regards laboratory parameters, we observed higher troponin levels and lower platelet and lymphocyte counts in patients with acute cerebral ischemia. Routine hemostatic and inflammatory laboratory parameters were comparable and within normal range in both groups. In-hospital mortality was significantly higher in patients with acute cerebral ischemia during acute SARS-CoV2 infection (Table). Consistently, reservoir mask was used more in these patients (18.8% vs 3.5 %, p=0.001). Conclusions. In a large cohort of patients hospitalized for acute Sars-CoV2 infection (n=1412), we found an incidence proportion of 1.3% of acute cerebral ischemia, 0.8% of IS. Specific patient-related features (age, hypertension, history of IS/TIA, ischemic heart disease/heart failure) seemed to influence the risk of acute cerebral ischemia during acute SARS-CoV-2 infection. In these patients, the early detection of IS/TIA is very important considering its impact on in-hospital mortality risk. Monitoring specific laboratory parameters of disease severity (platelet count, lymphocytes and tropinin level) could be useful.
SN - 2785-5309
ER -